NCT07016867 Medical Treatment Alone Versus Varicocelectomy Versus Varicocelectomy and Medical Treatment
| NCT ID | NCT07016867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | South Valley University |
| Condition | Teratozoospermia |
| Study Type | INTERVENTIONAL |
| Enrollment | 126 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2025-08-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 126 participants in total. It began in 2024-09-01 with a primary completion date of 2025-08-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A varicocele is defined as an abnormal venous dilatation and/or tortuosity of the pampiniform plexus in the scrotum. Although varicoceles are almost always and more common on the left side, up to 50% of the men with varicocele, have bilateral varicoceles. Varicocele has a negative impact on spermatogenesis, testicular volume, Standard semen parameters, and fertilization, implantation, and embryo outcomes.
Eligibility Criteria
Inclusion Criteria: * Sub-fertile men with clinically palpable varicoceles ( unilateral or bilateral ). * Men with teratozoospermia. Exclusion Criteria: * Recurrent varicoceles. * Significant medical diseases as: Hepatic insufficiency. * Hypersensitivity to the drugs. * Female factor of infertility.
Contact & Investigator
Mohammad Sayed Abdel-Kader, Professor
STUDY CHAIR
Urology Department, Faculty of Medicine, South Valley University, Qena, Egypt
Frequently Asked Questions
Who can join the NCT07016867 clinical trial?
This trial is open to male participants only, aged 20 Years or older, up to 50 Years, studying Teratozoospermia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07016867 currently recruiting?
Yes, NCT07016867 is actively recruiting participants. Contact the research team at marwan13156@gmail.com for enrollment information.
Where is the NCT07016867 trial being conducted?
This trial is being conducted at Qina, Egypt.
Who is sponsoring the NCT07016867 clinical trial?
NCT07016867 is sponsored by South Valley University. The principal investigator is Mohammad Sayed Abdel-Kader, Professor at Urology Department, Faculty of Medicine, South Valley University, Qena, Egypt. The trial plans to enroll 126 participants.